BPC-157 + TB-500 (10 mg Blend) Dosage Protocol

Also known as: Body Protection Compound-157 + Thymosin Beta-4 fragment

Advanced blend for tissue repair, wound healing, and recovery.

Dose range
600-1000 mcg daily
Route
Subcutaneous
Frequency
Once daily
Cycle length
8-12 weeks

This blend combines two potent regenerative peptides, BPC-157 and TB-500, to support tissue repair and healing. It is typically administered via subcutaneous injection once daily, with doses ranging from 600-1000 mcg. The protocol involves reconstituting the 10 mg blend with bacteriostatic water for accurate measurement.

  • Combines BPC-157 and TB-500 for enhanced healing.
  • Administered once daily via subcutaneous injection.
  • Typical cycle length is 8-12 weeks.
  • Reconstituted with 3 mL of bacteriostatic water for easy dosing.

Reconstitution

Vial strength

10 mg

Bacteriostatic water

3 mL

Concentration

3.33 mg/mL

1 unit on a U-100 syringe = 0.01 mL = 33.3 mcg total blend

  1. 1Draw 3.0 mL of bacteriostatic water using a sterile syringe.
  2. 2Inject the water slowly down the inside wall of the peptide vial, avoiding direct contact with the powder.
  3. 3Do not shake the vial. Gently swirl or roll it between your hands until the powder is fully dissolved.
  4. 4Label the reconstituted vial with the date and store it in the refrigerator at 2-8 °C (35.6-46.4 °F), protected from light.

Dosing schedule

PhaseDoseOn a U-100 syringe
Weeks 1-2 (Initial)600 mcg total blend (300 mcg BPC-157 + 300 mcg TB-500)18 units (0.18 mL)
Weeks 3-4 (Loading)800 mcg total blend (400 mcg BPC-157 + 400 mcg TB-500)24 units (0.24 mL)
Weeks 5-8 (Maintenance)600 mcg total blend (300 mcg BPC-157 + 300 mcg TB-500)18 units (0.18 mL)

Protocol detail

StartBegin with 600 mcg total daily (300 mcg of each peptide) for Weeks 1–2.
LoadingIncrease the dose to 800 mcg daily for Weeks 3–4.
MaintenanceReturn to 600 mcg daily for Weeks 5–8 and potentially longer.
FrequencyInject once per day (subcutaneous).
Cycle LengthTypically 8–12 weeks; an optional extension to 16 weeks may be considered.

Overview at a glance

GoalSupport tissue repair, wound healing, and recovery from musculoskeletal injuries.
ScheduleDaily subcutaneous injections for 8–12 weeks (extend to 16 weeks if needed).
Dose Range600–1000 mcg total blend daily (300–500 mcg of each peptide).
Reconstitution3.0 mL of bacteriostatic water per 10 mg vial (~3.33 mg/mL total concentration) for accurate unit measurements.
StorageLyophilized powder frozen; reconstituted solution refrigerated; avoid repeated freeze–thaw cycles.

How it works

BPC-157, a stable peptide from gastric juice, promotes blood vessel formation and possesses protective effects across various tissues including digestive, muscle, and nerve systems. It acts at very low doses without toxicity. TB-500, derived from Thymosin Beta-4, encourages cell movement, aids in wound healing, and exhibits anti-inflammatory properties. This blend leverages the complementary actions of BPC-157 for its regenerative and anti-inflammatory benefits, and TB-500 for enhanced cell migration and angiogenesis, offering a synergistic approach to tissue repair and recovery.

Reported effects

  • Accelerated healing of tendons, ligaments, muscles, and soft tissue injuries.
  • Gastroprotective and anti-inflammatory properties (BPC-157).
  • Promotes wound healing and may reduce scarring (TB-500).

Reported side effects

  • Occasional mild injection-site reactions (redness, itching).
  • No significant toxicity documented up to high doses in animal studies.

Storage

Lyophilised (unmixed)

Store at -20 °C (-4 °F) in dry, dark conditions; minimize moisture exposure.

After reconstitution

Refrigerate at 2-8 °C (35.6-46.4 °F); use within 4-6 weeks; avoid freeze-thaw cycles.

Supplies

Peptide vialsApproximately 4 vials for 8 weeks, 6 vials for 12 weeks, or 8 vials for 16 weeks (10 mg blend each).
Insulin Syringes (U-100)7 syringes per week (1/day); total of 56 for 8 weeks, 84 for 12 weeks, or 112 for 16 weeks.
Bacteriostatic Water (10 mL bottles)Requires 3.0 mL per vial for reconstitution; plan for 2 bottles for 8-12 weeks, or 3 bottles for 16 weeks.
Alcohol Swabs2 per day (one for vial stopper, one for injection site); approximately 2 x 100-count boxes for 8-12 weeks, or 3 x 100-count boxes for 16 weeks.

Important notes

  • This blend is for research purposes only and not approved for routine human use.
  • Banned in competitive sports.
  • Always use a new sterile insulin syringe for each injection.
  • Rotate injection sites to prevent local irritation and lipohypertrophy.
  • Inject slowly and document daily doses and injection sites.

Frequently asked questions

What is the reconstitution ratio for BPC-157 + TB-500 10 mg blend?

For this 10 mg blend, you should reconstitute with 3.0 mL of bacteriostatic water. This yields a concentration of approximately 3.33 mg/mL total.

How do I measure the correct dose using a U-100 insulin syringe?

After reconstituting with 3.0 mL of water, 1 unit on a U-100 insulin syringe will be equivalent to about 33.3 mcg of the total blend. For example, a 600 mcg dose would be 18 units.

What is the difference between the 'Standard' and 'Advanced' protocols?

The 'Standard' protocol uses a gradual increase in dosage over the first few weeks, while the 'Advanced' protocol suggests a higher initial loading dose for acute injury support, which then tapers down.

How often should I inject this blend and for how long?

The blend is injected subcutaneously once daily. The typical cycle length is 8-12 weeks, but it can be extended to 16 weeks if necessary, followed by a break.

Educational reference only. These figures summarise how BPC-157 + TB-500 is commonly described in research literature and supplier documentation, including the BPC-157 + TB-500 listing at peptidesuk4u.co.uk. They are not a prescription, not medical advice, and not a recommendation to self-administer anything.

Related protocols

Back to all protocols